#health insurance

Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.

But that doesn’t mean the Affordable Care Act is safe. Here’s what’s up next.

Adults with chronic liver disease are more than twice as likely than those without the condition to have barriers to medical care.

A new study shows that people with the liver disease have substantial financial burden that can impact their care.

Medicare plans vary and can sometimes be difficult to decipher. Does your plan cover hepatitis C treatment?

A look at the supply chain that results in very high costs for HIV and hepatitis C medications.

Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.

Health care facilities serving people who use drugs are well-positioned to initiate hepatitis C testing. But they don’t.

These two men both recently discovered that they had hepatitis C, each with a different story about their encounters with insurance.

Plans have increasingly instituted preauthorization requirements for the opioid medication-assisted treatment buprenorphine.

Don’t delay! But be aware of these changes to the 2019 Affordable Care Act marketplace.

Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.

That is compared with people who have hep C who had other types of insurance coverage.

A new law in Iowa allows “health benefit plans” that don’t meet federal insurance requirements.

60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.

This is according to an analysis of hep C treatment rates at four large urban hospital systems.